Range
6.98 - 7.2
Vol / Avg.
451.7K/1.3M
Div / Yield
-
52 Wk
6.1 - 22.74
Mkt Cap
515.8M
Payout Ratio
-
Open
7.02
P/E
-
EPS
-0.8
Shares
73.5M
Outstanding
73.5M
Total Float
41.8M
load more
Sector: Health Care.Industry: Pharmaceuticals
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused in the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. It develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-04
REV
Q2 2021Est.ActualSurprise
EPS-1.010-0.800 0.2100
REV15.410M12.914M-2.496M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
TBPHTheravance Biopharma-0.99%515.8M

Theravance Biopharma Questions & Anwsers

Q

How do I buy Theravance Biopharma (TBPH) stock?

A

You can purchase shares of Theravance Biopharma (NASDAQ: TBPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Theravance Biopharma's (TBPH) competitors?

Q

What is the target price for Theravance Biopharma (TBPH) stock?

A

The latest price target for Theravance Biopharma (NASDAQ: TBPH) was reported by Morgan Stanley on September 16, 2021. The analyst firm set a price target for 10.00 expecting TBPH to rise to within 12 months (a possible 42.45% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Theravance Biopharma (TBPH)?

A

The stock price for Theravance Biopharma (NASDAQ: TBPH) is $7.02 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Theravance Biopharma (TBPH) pay a dividend?

A

There are no upcoming dividends for Theravance Biopharma.

Q

When is Theravance Biopharma (NASDAQ:TBPH) reporting earnings?

A
Theravance Biopharma’s Q3 earnings are confirmed for after-market on November 4, 2021.
Q

Is Theravance Biopharma (TBPH) going to split?

A

There is no upcoming split for Theravance Biopharma.

Q

What sector and industry does Theravance Biopharma (TBPH) operate in?

A

Theravance Biopharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.